Your browser doesn't support javascript.
loading
Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.
Tanaka, Nobumichi; Nakai, Yasushi; Asakawa, Isao; Yamaki, Kaori; Miyake, Makito; Hori, Shunta; Owari, Takuya; Fujii, Tomomi; Fujimoto, Kiyohide.
Afiliação
  • Tanaka N; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Nakai Y; Department of Prostate Brachytherapy, Nara Medical University, Kashihara, Japan.
  • Asakawa I; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Yamaki K; Department of Prostate Brachytherapy, Nara Medical University, Kashihara, Japan.
  • Miyake M; Department of Radiation Oncology, Nara Medical University, Kashihara, Japan.
  • Hori S; Department of Radiation Oncology, Nara Medical University, Kashihara, Japan.
  • Owari T; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Fujii T; Department of Urology, Nara Medical University, Kashihara, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, Kashihara, Japan.
Int J Urol ; 29(12): 1560-1568, 2022 12.
Article em En | MEDLINE | ID: mdl-36125928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Braquiterapia Idioma: En Ano de publicação: 2022 Tipo de documento: Article